Rituximab for treatment of ocular inflammatory disease: A series of four cases

Research output: Contribution to journalArticle

41 Scopus citations

Abstract

Rituximab may be effective in the treatment of ocular inflammatory disease. Dosing is less frequent than many medications currently available. Four cases are reported, each of which appeared to have responded well to treatment with rituximab, although patient 2 was able to remain on a low dose of prednisone for only 2 months. The ongoing pilot study will hopefully provide additional insight into the benefit of rituximab for treatment of scleritis and idiopathic orbital inflammatory disease.

Original languageEnglish (US)
Pages (from-to)546-548
Number of pages3
JournalBritish Journal of Ophthalmology
Volume93
Issue number4
DOIs
StatePublished - Apr 1 2009

ASJC Scopus subject areas

  • Ophthalmology
  • Sensory Systems
  • Cellular and Molecular Neuroscience

Fingerprint Dive into the research topics of 'Rituximab for treatment of ocular inflammatory disease: A series of four cases'. Together they form a unique fingerprint.

  • Cite this